The observation that CAV2 is a modifier of age-of-onset of chronic P. aeruginosa airway infection in individuals with CF is strongly supported by functional studies of caveolin-2 and its dimeric complement, caveolin-1. Here, CAV1 is linked to cystic fibrosis.